Pharmacologic treatment of first-episode schizophrenia: Early intervention is key to outcome

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 19, 1998, Pages 9-17

  DeQuardo, John R ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; CASE REPORT; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SOMNOLENCE; TARDIVE DYSKINESIA; TREATMENT OUTCOME; VERTIGO;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIAGNOSIS, DIFFERENTIAL; ELECTROCONVULSIVE THERAPY; EPISODE OF CARE; HUMANS; PIRENZEPINE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0032427812     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Cole JO, Goldberg SC, Klerman GL. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry 1964;10:246-261
2. Loebel AD, Lieberman JA, Alvir JMJ, et al. Duration of psychosis and outcome in first-episode schizophrenia. Arch Gen Psychiatry 1992;149:1183-1188
3. Olin SS, Mednick SA. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr Bull 1996;22:223-240
4. Jibson MD, Tandon R, O'Connor TP. Psychosis and schizophrenia. In: Knesper DJ, Riba MB, Schwenk TL, eds. Primary Care Psychiatry. Philadelphia, Pa: WB Saunders; 1997:163-183
5. American Psychiatric Association. Practice guidelines for the treatment of patients with schizophrenia. Am J Psychiatry 1997;154(suppl 4):35
6. The Expert Consensus Guideline Series: Treatment of Schizophrenia. J Clin Psychiatry 1996;57(suppl 12B):31
7. Larson EB, Mack LA, Watts B, et al. Computed tomography in patients with psychiatric illnesses: advantage of a "rule-in" approach. Ann Intern Med 1981;95:360-364
8. Wahlund L, Agartz I, Saaf J, et al. MRI in psychiatry: 731 cases. Psychiatry Res: Neuroimaging 1992;45:139-140
9. Lieberman J, Jody D, Geisler S, et al. Treatment outcome of first episode schizophrenia. Psychopharmacol Bull 1989;25:92-96
10. Falkai P. Differential diagnosis in acute psychotic episode. Int Clin Psychopharmacol 1996;11(suppl 2):13-17
11. Gerwitz G, Squires-Wheeler E, Sharif Z, et al. Results of computerised tomography during first admission psychosis. Br J Psychiatry 1994;164: 789-795
12. Panzer MJ, DeQuardo JR, Abelson JL. Delayed diagnosis of a frontal meningioma. Ann Clin Psychiatry 1991;3:259-262
13. Johnstone EC, MacMillan JF, Crow TJ. The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med 1987;17:371-379
14. Davidson K. Schizophrenia-like psychoses associated with organic cerebral disorders: a review. Psychiatr Dev 1983;1:1-34
15. Milner K, Tandon R, Tomori O, et al. Psychotropic medications and sexual dysfunction. In: Buckley PF, ed. Sexuality Among Patients With Serious Mental Illness. Washington, DC: American Psychiatric Press. In press
16. Falloon IRH, Boyd JL, McGill CW, et al. Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry 1985;42:887-896
17. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
18. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:11-19
19. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised Version. Bethesda, Md: US Department of Health, Education and Welfare; 1976
20. Tandon R, Jibson MD, Taylor SF, et al. Conceptual models of the relationship between positive and negative symptoms. In: Shriqui CL, Nasrallah HA, eds. Contemporary Issues in the Treatment of Schizophrenia. Washington, DC: American Psychiatric Press; 1995:109-124
21. Lieberman J, Jody D, Giesler S, et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376
22. Endicott J, Spitzer RL. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978;35:837-844
23. Guy W. Clinical Global Impression Scale. In: ECDEU Assessment Manual for Psychopharmacology. Washington, DC: Department of Health, Education and Welfare; 1976
24. Kane J, Woerner M, Lieberman J, et al. Tardive dyskinesia and drugs. Drug Dev Res 1986;9:41-51
25. Tollefson GD, Beasley CM, Tamura RN, et al. Blind controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248-1254
26. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
27. Kopala LC, Frcdrikson D, Good KP, et al. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone. Biol Psychiatry 1996;39:296-298
28. McCreadie RG. Managing the first episode of schizophrenia: the role of new therapies. Eur Neuropsychopharmacol 1996;6(suppl 2):S3-S5
29. Beasley CM, Tollefson GD, Tran P, et al. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsycopharmacology 1996;14:111-123
30. Tollefson GD, Beasley CM, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-465
31. Tollefson GD, Sanger TM, Lieberman JA. Olanzapine versus haloperidol in the treatment of first episode psychosis [abstract]. Schizophr Res 1997;24:193
32. Kellner CH. Is ECT the treatment of choice for first-break psychosis? Convuls Ther 1995;11:155-157
33. Salzman C. The use of ECT in the treatment of schizophrenia. Am J Psychiatry 1980;137:1032-1041
34. Fink M, Sackeim HA. Convulsive therapy in schizophrenia? Schizophr Bull 1996;22:27-39
35. Kane JM. Innovations in the pharmacologic treatment of schizophrenia. In: Bellack AS, ed. A Clinical Guide for the Treatment of Schizophrenia. New York, NY: Plenum Press; 1989:43-75
36. Lieberman JA, Koreen AR, Chakos M, et al. Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 1996;57(suppl 9):5-9
37. Crow TJ, Mac Millan JF, Johnstone AL, et al. A randomized controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986;148:120-127
38. McEvoy JP, Schooler NR, Wilson WH. Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 1991;27:97-101
39. Tsoi WF, Wong KE. A 15-year follow-up study of Chinese schizophrenic patients. Acta Psychiatr Scand 1991;84:217-220
40. Rzewuska M. Duration of untreated psychosis during first year of illness as a predictor of proanosis in schizophrenia. Eur Neuropsychopharmacol 1994;4:393-395
41. May PRA, Tuma AH, Dixon WJ. Schizophrenia: a follow-up study of results of treatment, II: hospital stay over two to five years. Arch Gen Psychiatry 1976;33:481-486
42. May PRA, Tuma AH, Dixon WJ, et al. Schizophrenia: a follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981;38: 776-784
43. Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychol Med 1997;27:261-268
44. Wyatt RJ. Neuroleptics and the natural course of schizophrenia'. Schizophr Bull 1991;17:325-351
45. McGlashan TH, Fenton WS. The positive-negative distinction in schizophrenia: review of natural history vaudators. Arch Gen Psychiatry 1992;49:63-72
46. Kemali D, Maj M, Galderisi S, et al. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study. Biol Psychiatry 1989;26:756-759
47. Woods BT, Yurgelun-Tbdd D, Benes FM, et al. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 1990;27:341-352
48. Illowsky BP, Juliono DM, Bigelow LB, et al. Stability of CT scan findings: results of an 8-year follow-up study. J Neurol Neurosurg Psychiatry 1988;51:209-213
49. Jaskiw GE, Juliano DM, Goldberg TE, et al. Cerebral ventricular enlargement in schizophreniform disorder does not progress: a seven year follow-up study. Schizophr Res 1994;14:23-28
50. DeLisi LE, Sakuma M, Tew W, et al. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res: Neuroimaging 1997;74: 129-140
51. Nair TR, Christensen JD, Kingsbury SJ, et al. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res: Neuroimaging 1997;74:141-150
52. Steinberg JL, Devous MD, Paulman RG, et al. Regional cerebral blood flow in first break and chronic schizophrenic patients and normal controls. Schizophr Res 1995;17:229-240
53. Hyde TM, Nawroz S, Goldberg TE, et al. Is there cognitive decline in schizophrenia? a cross-sectional study. Br J Psychiatry 1994;164:494-500
54. Bilder RM, Lipschutz-Broch L, Reiter G, et al. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992;18:437-448
55. DeQuardo JR, Tandon R, Goldman R, et al. Ventricular enlargement, neuropsychological status, and premorbid function in schizophrenia. Biol Psychiatry 1994;35:517-524
56. Walker EF, Grimes KE, Davis DM, et al. Childhood precursors of schizophrenia: facial expressions of emotion. Am J Psychiatry 1993;150: 1654-1660
57. Mednick SA, Silverton L. High-risk studies of the etiology of schizophrenia. In: Tsuang MT, Simpson JC, eds. Handbook of Schizophrenia, Nosology, Epidemiology, and Genetics of Schizophrenia, vol. 3. New York, NY: Elsevier Science; 1988:543-562
58. Chapman JP. The early symptoms of schizophrenia. Br J Psychiatry 1966;112:225-251
59. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353-370
60. Falloon IRH, Kydd RR, Coverdale JH, et al. Early detection and intervention for initial episodes of schizophrenia. Schizophr Bull 1996;22:271-282
61. McGlashan TH, Johannessen JO. Early detection and intervention with schizophrenia: rationale. Schizophr Bull 1996;22:201-222